JUNE 20256LIFE SCIENCES REVIEWRegulatory services providers are increasingly integrating advanced technologies to streamline compliance and accelerate product approvals. The use of AI and machine learning in regulatory intelligence has expanded, helping life sciences firms monitor policy changes, predict review outcomes and automate dossier preparation. Cloud-based platforms are being adopted for real-time document management and collaboration across global regulatory teams, while natural language processing tools assist in aligning submission content with regional requirements. Another revolution is unfolding. 3D bioprinting is breaking new ground as advances in tissue engineering meet the precision of AI. It has moved beyond experimental curiosity to become a core enabler in personalized healthcare and regenerative therapies. A most compelling shift this year has been the convergence of AI with bioprinting platforms, where machine learning models are helping refine cell-laden bioink formulations and optimize printing paths for higher fidelity, cell viability and reproducibility. This marriage of automation and biology is reducing the trial-and-error phase that once slowed the field.Driven by these trends, the regulatory services market is projected to grow at a CAGR of 8.6 percent by 2034. Meanwhile, the 3D bioprinting industry is expected to expand from $2.55 billion in 2025 to $8.57 billion by 2035, registering a CAGR of 12.9 percent.The magazine features a thought leadership piece by Amber Howard, Director of Corporate Risk Management at Infirmary Health, discussing the importance of cross-departmental collaboration and a just culture in advancing patient safety and risk mitigation. Additionally, it includes insights from Vanessa Casella, Program Manager, Compliance Risk & Data Service at UChicago Medicine, on the value of collaboration and continuous learning in ensuring patient-centered, compliant care.We also spotlight the stories of regulatory services companies delivering solutions that drive innovation. One such company is Health Policy Associates, which has provided consulting services to companies developing new medical device technologies, pharmaceuticals and biologics for over 30 years.In this edition, featuring Top Regulatory Services Providers 2025 and 3D Bioprinting Solutions Company of the Year 2025, we hope you find the right partner to meet your organization's needs.Let us know your thoughts!EDITORIALThe Tech Convergence Transforming Life SciencesCopyright © 2025 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com JUNE 16, 2025, Vol 06, Issue - 12 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersPresley MeadowDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsHenry SmithClara Matthew
< Page 5 | Page 7 >